GRAY MARY ANN Insider Trading
Get the latest insider transactions of GRAY MARY ANN. GRAY MARY ANN is Director in JUNIPER PHARMACEUTICALS INC ($JNP) and Director in Sarepta Therapeutics, Inc. ($SRPT) and in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SENOMYX INC ($SNMX) and Director in Seneca Biopharma, Inc. ($SNCA) and Director in Galena Biopharma, Inc. ($GALE) and Director in Keros Therapeutics, Inc. ($KROS) and in RAPT Therapeutics, Inc. ($RAPT) and Director in RAPT Therapeutics, Inc. ($RAPT). Discover the current value of GRAY MARY ANN shares.
Address: 3165 PORTER DRIVE PALO ALTO 94304CA
GRAY MARY ANN is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
MBVX | MABVAX THERAPEUTICS HOLDINGS, INC. | Director | 5,000 | 14,850.00 |
DYAX | DYAX CORP | 0 | 0.00 | |
SNMX | SENOMYX INC | Director | 0 | 0.00 |
ACAD | ACADIA PHARMACEUTICALS INC | 149,476 | 5,708,488.44 | |
SLS | SELLAS Life Sciences Group, Inc. | Director | 39,167 | 54,833.80 |
JNP | JUNIPER PHARMACEUTICALS INC | Director | 0 | 0.00 |
SRPT | Sarepta Therapeutics, Inc. | Director | 8,436 | 246,078.12 |
RAPT | RAPT Therapeutics, Inc. | 0 | ||
SNCA | PALISADE BIO, INC. | Director | 0 | 0.00 |
KROS | Keros Therapeutics, Inc. | Director | 0 |
Insider Trading Transactions of GRAY MARY ANN
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | RAPT | RAPT Therapeutics, Inc. | GRAY MARY ANN | Option Exercise | 19.30 | 7,500 | 144,750 | 7,500 | |
Apr 26 2021 | SNCA | Seneca Biopharma, Inc. | GRAY MARY ANN | Director | Option Exercise | 0.00 | 6,000 | 0 | 6,000 |
Apr 02 2021 | RAPT | RAPT Therapeutics, Inc. | GRAY MARY ANN | Option Exercise | 22.20 | 3,822 | 84,848 | 3,822 | |
Mar 05 2021 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Buy | 0.00 | 2,726 | 0 | 8,436 |
Mar 05 2021 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 87.11 | 5,518 | 480,673 | 5,518 |
Dec 21 2020 | KROS | Keros Therapeutics, Inc. | GRAY MARY ANN | Director | Option Exercise | 82.74 | 16,587 | 1,372,408 | 16,587 |
Dec 10 2020 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Buy | 0.00 | 967 | 0 | 5,710 |
Dec 10 2020 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 0.00 | 967 | 0 | 967 |
Jun 19 2020 | RAPT | RAPT Therapeutics, Inc. | GRAY MARY ANN | Director | Option Exercise | 28.27 | 7,500 | 212,025 | 7,500 |
Apr 07 2020 | SNCA | Seneca Biopharma, Inc. | GRAY MARY ANN | Director | Option Exercise | 0.00 | 6,000 | 0 | 6,000 |
Apr 02 2020 | RAPT | RAPT Therapeutics, Inc. | GRAY MARY ANN | Director | Option Exercise | 21.27 | 3,984 | 84,740 | 3,984 |
Feb 28 2020 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Buy | 0.00 | 2,075 | 0 | 4,743 |
Feb 28 2020 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 114.47 | 3,685 | 421,822 | 3,685 |
Dec 10 2019 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Buy | 0.00 | 967 | 0 | 2,668 |
Dec 10 2019 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 0.00 | 967 | 0 | 1,934 |
Dec 06 2019 | RAPT | RAPT Therapeutics, Inc. | GRAY MARY ANN | Director | Option Exercise | 27.53 | 22,500 | 619,425 | 22,500 |
Mar 04 2019 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Buy | 0.00 | 1,633 | 0 | 1,701 |
Mar 04 2019 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 145.48 | 3,213 | 467,427 | 3,213 |
Dec 11 2018 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 122.80 | 5,711 | 701,311 | 5,711 |
Dec 11 2018 | SRPT | Sarepta Therapeutics, Inc ... | GRAY MARY ANN | Director | Option Exercise | 0.00 | 2,901 | 0 | 2,901 |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Sell | 1.50 | 10,000 | 15,000 | 0 |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 0.90 | 20,000 | 17,970 | 0 |
Nov 02 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 1.36 | 20,000 | 27,200 | 0 |
Aug 15 2018 | JNP | JUNIPER PHARMACEUTICALS I ... | GRAY MARY ANN | Director | Sell | 11.50 | 16,244 | 186,806 | 0 |
May 25 2018 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 1.36 | 20,000 | 27,200 | 20,000 |
Oct 10 2017 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Buy | 0.38 | 15,472 | 5,879 | 39,167 |
Jul 06 2017 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Buy | 0.59 | 9,866 | 5,821 | 23,695 |
Jul 06 2017 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Option Exercise | 0.55 | 5,000 | 2,750 | 5,000 |
May 22 2017 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 0.90 | 20,000 | 17,970 | 20,000 |
Apr 12 2017 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Buy | 0.59 | 8,815 | 5,201 | 13,829 |
Mar 27 2017 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Buy | 1.00 | 10,000 | 10,000 | 10,000 |
Jan 24 2017 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Buy | 1.98 | 2,525 | 5,000 | 5,004 |
Aug 03 2016 | JNP | JUNIPER PHARMACEUTICALS I ... | GRAY MARY ANN | Director | Buy | 0.00 | 6,064 | 0 | 7,334 |
Jul 18 2016 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Option Exercise | 0.41 | 100,000 | 41,000 | 100,000 |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 9.04 | 6,637 | 59,998 | 139,476 | |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 9.04 | 10,000 | 90,400 | 149,476 | |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 9.04 | 6,637 | 59,998 | 0 | |
Jun 09 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 9.04 | 10,000 | 90,400 | 0 | |
May 24 2016 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 2.13 | 20,000 | 42,600 | 20,000 |
Apr 28 2016 | GALE | Galena Biopharma, Inc. | GRAY MARY ANN | Director | Option Exercise | 1.40 | 200,000 | 280,000 | 200,000 |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 1.30 | 10,000 | 13,000 | 10,000 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 1.30 | 57,692 | 75,000 | 67,692 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 1.36 | 55,147 | 75,000 | 122,839 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Buy | 1.36 | 10,000 | 13,600 | 132,839 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 1.30 | 10,000 | 13,000 | 0 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 1.30 | 57,692 | 75,000 | 0 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 1.36 | 55,147 | 75,000 | 0 | |
Apr 07 2016 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 1.36 | 10,000 | 13,600 | 0 | |
Apr 06 2016 | JNP | JUNIPER PHARMACEUTICALS I ... | GRAY MARY ANN | Director | Buy | 0.00 | 1,270 | 0 | 1,270 |
Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Sell | 0.00 | 232,440 | 0 | 0 | |
Jan 22 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Option Exercise | 26.23 | 16,667 | 437,175 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 2.97 | 6,000 | 17,820 | 16,000 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 3.82 | 75,000 | 286,500 | 91,000 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 2.09 | 75,000 | 156,750 | 166,000 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 2.06 | 8,107 | 16,700 | 174,107 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 6.17 | 25,000 | 154,250 | 199,107 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Buy | 26.23 | 33,333 | 874,325 | 232,440 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 2.97 | 6,000 | 17,820 | 0 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 3.82 | 75,000 | 286,500 | 0 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 2.09 | 75,000 | 156,750 | 0 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 2.06 | 8,107 | 16,700 | 0 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 6.17 | 25,000 | 154,250 | 0 |
Jan 19 2016 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 26.23 | 33,333 | 874,325 | 16,667 |
Jun 17 2015 | ACAD | ACADIA PHARMACEUTICALS IN ... | GRAY MARY ANN | Option Exercise | 39.06 | 12,500 | 488,250 | 12,500 | |
May 22 2015 | SNMX | SENOMYX INC | GRAY MARY ANN | Director | Option Exercise | 5.47 | 20,000 | 109,400 | 20,000 |
May 14 2015 | DYAX | DYAX CORP | GRAY MARY ANN | Director | Option Exercise | 26.23 | 50,000 | 1,311,500 | 50,000 |
May 31 2005 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Option Exercise | 14.56 | 5,000 | 72,800 | 5,000 |
Mar 17 2005 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Buy | 15.69 | 100 | 1,569 | 100 |
Mar 17 2005 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Buy | 15.47 | 2,650 | 40,996 | 2,750 |
Mar 17 2005 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Buy | 15.48 | 500 | 7,740 | 3,250 |
Mar 17 2005 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Buy | 15.70 | 1,750 | 27,475 | 5,000 |
May 14 2004 | MBVX | MABVAX THERAPEUTICS HOLDI ... | GRAY MARY ANN | Director | Option Exercise | 23.25 | 5,000 | 116,250 | 5,000 |